Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Cell Cycle Changes, DNA Ploidy, and PTTG1 Gene Expression in HTLV-1 Patients

Full text
Author(s):
Levy, Debora [1] ; Ferreira, Mari Cleia M. R. [2] ; Reichert, Cadiele O. [1] ; de Almeida, Lis Vilela [2] ; Brocardo, Graciela [2] ; Lage, Luis Alberto P. C. [2] ; Culler, Hebert F. [2] ; Nukui, Youko [3] ; Bydlowski, Sergio P. [1] ; Pereira, Juliana [4]
Total Authors: 10
Affiliation:
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Immunol LIM19, Lipids Oxidat & Cell Biol Team, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Med, Dept Hematol Hemotherapy & Cell Therapy, Sao Paulo - Brazil
[3] Univ Sao Paulo, Prosangue Fdn, Sch Med, Dept Hematol Hemotherapy & Cell Therapy, Sao Paulo - Brazil
[4] Univ Sao Paulo, Sch Med, Lab Med Invest Pathogenesis & Targeted Therapy On, Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: FRONTIERS IN MICROBIOLOGY; v. 11, JUL 24 2020.
Web of Science Citations: 0
Abstract

Human T-cell lymphotropic virus type-1 (HTLV-1) is a pathogenic retrovirus that is associated with adult T-cell leukemia/lymphoma (ATL). Genetic instability is the hallmark of ATL. Cell cycle progression is needed for virus particle reproduction. HTLV-1 encoded Tax protein ultimately disrupts the mitotic spindle checkpoint, leading to incorrect chromosome segregation, resulting in aneuploidy. Cell cycle abnormalities have been described in T cells transfected with HTLV-1 virusin vitro, but not in HTLV-1 asymptomatic carriers. PTTG1 and HTLV-1 viral protein Tax exhibit a cooperative transforming activity. Overexpressed PTTG1 results in chromosome instability and aneuploidy, which has been suggested as a mechanism underlying PTTG1 transforming activity. Here we aimed to investigate cell cycle, DNA ploidy and PTTG1 mRNA expression in CD4(+)and CD8(+)T cells in healthy subjects (HS), HTLV-1 asymptomatic carriers and ATL patients. We have identified that HTLV-1 asymptomatic carriers have shown DNA aneuploidy and cell cycle arrest at cell cycle phase G(0)/G(1)in CD4(+)T cells. CD8(+)T cells of HTLV-1 asymptomatic carriers also demonstrated DNA aneuploidy but without alteration in cell cycle. In ATL, CD4(+)and CD8(+)T cells present a higher number of cells in cell cycle S-phase and PTTG1 overexpression. These studies provide insight into malignant transformation of HTLV-1 asymptomatic carriers to ATL patients. (AU)

FAPESP's process: 11/22132-0 - Analysis of the hsecurin gene expression and DNA index in HTLV-1 carriers and patients with leukemia-lymphoma T-cell adult as markers of progression disease
Grantee:Juliana Pereira
Support Opportunities: Regular Research Grants